" class="no-js "lang="en-US"> Biotech Archives - Medtech Alert
Wednesday, June 19, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

AI Proteins Announces the Formation of a Scientific Advisory Board Made up of Experts in Biotech and FDA Drug Approval

AI Proteins, a growing biotechnology company that utilizes computational de novo protein design to create […]

smartbax Announces Seed Financing of €1.2 Million to Develop Next-generation Antibiotics

smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the close […]

Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases

Ironwood Pharmaceuticals, a GI-focused healthcare company, and VectivBio Holding AG, a clinical-stage biopharmaceutical company pioneering […]

Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as Chief Executive Officer

Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel […]

n-Lorem Foundation Awarded Prestigious 2023 Edison Award

n-Lorem, a nonprofit Foundation, today announced that it has been selected as a 2023 Edison […]

ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer

ImmVira, a biotechnology company focused on developing and synthesizing biological vector delivery platform, has announced […]

Novo Holdings Invests in US$105 Million Series C Funding of Alentis Therapeutics

Novo Holdings A/S, a leading international life sciences investor, today announced it has participated in […]

ProJenX Announces Formation of Scientific Advisory Board for Development of ALS Treatment

ProJenX, a clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined pathways for the treatment […]

Granular Therapeutics to Accelerate Development of Next-Generation Pipeline for Treating Mast Cell Driven Diseases

Granular Therapeutics, a private biotech company specialising in precision biologic therapies for treating mast cell […]

PharmaVentures Establishes an Office in Seoul to Enhance Access for South Korean Biotechs

PharmaVentures announces its new office in South Korea as part of its continued strategic expansion. […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more